Logo image of AMCX

AMC NETWORKS INC-A (AMCX) Stock Fundamental Analysis

NASDAQ:AMCX - Nasdaq - US00164V1035 - Common Stock

8.89  -0.18 (-1.98%)

After market: 8.89 0 (0%)

Fundamental Rating

4

Overall AMCX gets a fundamental rating of 4 out of 10. We evaluated AMCX against 91 industry peers in the Media industry. AMCX has an average financial health and profitability rating. AMCX has a bad growth rate and is valued cheaply. These ratings would make AMCX suitable for value investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

AMCX had positive earnings in the past year.
AMCX had a positive operating cash flow in the past year.
AMCX had positive earnings in each of the past 5 years.
AMCX had a positive operating cash flow in each of the past 5 years.
AMCX Yearly Net Income VS EBIT VS OCF VS FCFAMCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

1.2 Ratios

AMCX has a Return On Assets (0.78%) which is in line with its industry peers.
AMCX has a better Return On Equity (3.35%) than 62.79% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.27%, AMCX is in the better half of the industry, outperforming 68.60% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AMCX is above the industry average of 6.90%.
Industry RankSector Rank
ROA 0.78%
ROE 3.35%
ROIC 6.27%
ROA(3y)2.94%
ROA(5y)4.04%
ROE(3y)16.98%
ROE(5y)29.4%
ROIC(3y)9.06%
ROIC(5y)9.88%
AMCX Yearly ROA, ROE, ROICAMCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400 -600 -800

1.3 Margins

AMCX has a Profit Margin (1.50%) which is comparable to the rest of the industry.
AMCX's Profit Margin has declined in the last couple of years.
The Operating Margin of AMCX (15.12%) is better than 82.56% of its industry peers.
In the last couple of years the Operating Margin of AMCX has declined.
AMCX has a better Gross Margin (50.66%) than 62.79% of its industry peers.
In the last couple of years the Gross Margin of AMCX has remained more or less at the same level.
Industry RankSector Rank
OM 15.12%
PM (TTM) 1.5%
GM 50.66%
OM growth 3Y-8.08%
OM growth 5Y-7.48%
PM growth 3Y-2.32%
PM growth 5Y-11.95%
GM growth 3Y-1.4%
GM growth 5Y-0.76%
AMCX Yearly Profit, Operating, Gross MarginsAMCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

AMCX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AMCX has been increased compared to 1 year ago.
Compared to 5 years ago, AMCX has less shares outstanding
Compared to 1 year ago, AMCX has an improved debt to assets ratio.
AMCX Yearly Shares OutstandingAMCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
AMCX Yearly Total Debt VS Total AssetsAMCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.77, we must say that AMCX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.77, AMCX is in the better half of the industry, outperforming 68.60% of the companies in the same industry.
AMCX has a debt to FCF ratio of 6.56. This is a slightly negative value and a sign of low solvency as AMCX would need 6.56 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.56, AMCX is in the better half of the industry, outperforming 65.12% of the companies in the same industry.
A Debt/Equity ratio of 2.10 is on the high side and indicates that AMCX has dependencies on debt financing.
With a Debt to Equity ratio value of 2.10, AMCX is not doing good in the industry: 72.09% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 6.56
Altman-Z 1.77
ROIC/WACC1.14
WACC5.49%
AMCX Yearly LT Debt VS Equity VS FCFAMCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

AMCX has a Current Ratio of 2.32. This indicates that AMCX is financially healthy and has no problem in meeting its short term obligations.
AMCX has a Current ratio of 2.32. This is in the better half of the industry: AMCX outperforms 70.93% of its industry peers.
A Quick Ratio of 2.32 indicates that AMCX has no problem at all paying its short term obligations.
AMCX's Quick ratio of 2.32 is fine compared to the rest of the industry. AMCX outperforms 70.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 2.32
AMCX Yearly Current Assets VS Current LiabilitesAMCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

More info and screens

0

3. Growth

3.1 Past

AMCX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -55.27%.
The Earnings Per Share has been decreasing by -3.58% on average over the past years.
Looking at the last year, AMCX shows a very negative growth in Revenue. The Revenue has decreased by -16.57% in the last year.
AMCX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.81% yearly.
EPS 1Y (TTM)-55.27%
EPS 3Y-3%
EPS 5Y-3.58%
EPS Q2Q%-50.81%
Revenue 1Y (TTM)-16.57%
Revenue growth 3Y-1.24%
Revenue growth 5Y-1.81%
Sales Q2Q%-5.86%

3.2 Future

The Earnings Per Share is expected to decrease by -16.61% on average over the next years. This is quite bad
Based on estimates for the next years, AMCX will show a decrease in Revenue. The Revenue will decrease by -2.79% on average per year.
EPS Next Y-40.61%
EPS Next 2Y-30.09%
EPS Next 3Y-22.33%
EPS Next 5Y-16.61%
Revenue Next Year-10.13%
Revenue Next 2Y-6.22%
Revenue Next 3Y-4.39%
Revenue Next 5Y-2.79%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMCX Yearly Revenue VS EstimatesAMCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
AMCX Yearly EPS VS EstimatesAMCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

AMCX is valuated cheaply with a Price/Earnings ratio of 2.21.
96.51% of the companies in the same industry are more expensive than AMCX, based on the Price/Earnings ratio.
AMCX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.96.
The Price/Forward Earnings ratio is 2.52, which indicates a rather cheap valuation of AMCX.
100.00% of the companies in the same industry are more expensive than AMCX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 24.11. AMCX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.21
Fwd PE 2.52
AMCX Price Earnings VS Forward Price EarningsAMCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

90.70% of the companies in the same industry are more expensive than AMCX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMCX indicates a rather cheap valuation: AMCX is cheaper than 97.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.09
EV/EBITDA 4.03
AMCX Per share dataAMCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

AMCX has a very decent profitability rating, which may justify a higher PE ratio.
AMCX's earnings are expected to decrease with -22.33% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.09%
EPS Next 3Y-22.33%

More info and screens

0

5. Dividend

5.1 Amount

AMCX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMC NETWORKS INC-A

NASDAQ:AMCX (1/17/2025, 8:00:00 PM)

After market: 8.89 0 (0%)

8.89

-0.18 (-1.98%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)02-07 2025-02-07/amc
Inst Owners128.83%
Inst Owner Change0.04%
Ins Owners5.01%
Ins Owner Change1.94%
Market Cap392.23M
Analysts46.67
Price Target9.69 (9%)
Short Float %18%
Short Ratio7.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.48%
Min EPS beat(2)-19.95%
Max EPS beat(2)42.91%
EPS beat(4)1
Avg EPS beat(4)-7.44%
Min EPS beat(4)-31.78%
Max EPS beat(4)42.91%
EPS beat(8)5
Avg EPS beat(8)22.41%
EPS beat(12)7
Avg EPS beat(12)25.5%
EPS beat(16)11
Avg EPS beat(16)61.96%
Revenue beat(2)2
Avg Revenue beat(2)1.05%
Min Revenue beat(2)0.04%
Max Revenue beat(2)2.05%
Revenue beat(4)2
Avg Revenue beat(4)-0.6%
Min Revenue beat(4)-2.96%
Max Revenue beat(4)2.05%
Revenue beat(8)3
Avg Revenue beat(8)-1.57%
Revenue beat(12)4
Avg Revenue beat(12)-3.19%
Revenue beat(16)7
Avg Revenue beat(16)-0.93%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)30.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 2.21
Fwd PE 2.52
P/S 0.16
P/FCF 1.09
P/OCF 1
P/B 0.35
P/tB N/A
EV/EBITDA 4.03
EPS(TTM)4.03
EY45.33%
EPS(NY)3.52
Fwd EY39.64%
FCF(TTM)8.14
FCFY91.6%
OCF(TTM)8.85
OCFY99.52%
SpS56.68
BVpS25.32
TBVpS-32.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.78%
ROE 3.35%
ROCE 9.22%
ROIC 6.27%
ROICexc 7.83%
ROICexgc 35.63%
OM 15.12%
PM (TTM) 1.5%
GM 50.66%
FCFM 14.37%
ROA(3y)2.94%
ROA(5y)4.04%
ROE(3y)16.98%
ROE(5y)29.4%
ROIC(3y)9.06%
ROIC(5y)9.88%
ROICexc(3y)11.07%
ROICexc(5y)12.1%
ROICexgc(3y)48.16%
ROICexgc(5y)43.72%
ROCE(3y)13.32%
ROCE(5y)14.51%
ROICexcg growth 3Y3.19%
ROICexcg growth 5Y1.73%
ROICexc growth 3Y-9.01%
ROICexc growth 5Y-6.81%
OM growth 3Y-8.08%
OM growth 5Y-7.48%
PM growth 3Y-2.32%
PM growth 5Y-11.95%
GM growth 3Y-1.4%
GM growth 5Y-0.76%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 6.56
Debt/EBITDA 4.87
Cap/Depr 30.09%
Cap/Sales 1.24%
Interest Coverage 2.57
Cash Conversion 81.1%
Profit Quality 960.56%
Current Ratio 2.32
Quick Ratio 2.32
Altman-Z 1.77
F-Score7
WACC5.49%
ROIC/WACC1.14
Cap/Depr(3y)39.82%
Cap/Depr(5y)50.93%
Cap/Sales(3y)1.37%
Cap/Sales(5y)1.75%
Profit Quality(3y)642.59%
Profit Quality(5y)464.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-55.27%
EPS 3Y-3%
EPS 5Y-3.58%
EPS Q2Q%-50.81%
EPS Next Y-40.61%
EPS Next 2Y-30.09%
EPS Next 3Y-22.33%
EPS Next 5Y-16.61%
Revenue 1Y (TTM)-16.57%
Revenue growth 3Y-1.24%
Revenue growth 5Y-1.81%
Sales Q2Q%-5.86%
Revenue Next Year-10.13%
Revenue Next 2Y-6.22%
Revenue Next 3Y-4.39%
Revenue Next 5Y-2.79%
EBIT growth 1Y-31.36%
EBIT growth 3Y-9.21%
EBIT growth 5Y-9.16%
EBIT Next Year-0.67%
EBIT Next 3Y-7.14%
EBIT Next 5Y-9.53%
FCF growth 1Y299.19%
FCF growth 3Y-37.83%
FCF growth 5Y-20.06%
OCF growth 1Y186.79%
OCF growth 3Y-35.18%
OCF growth 5Y-19.59%